Letter from Dr Craske at the PHLS to Dr Maycock at BPL discussing the scale of incidence of transfusion hepatitis and the requirement to report cases. The document also discusses the potential study of Lister Factor VIII products. These products would be compared with Hemofil and Kryobulin for a two year period beginning in January 1977.